reglab/statecodes huggingface dataset:
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-7 - Storage of information

Current through July 10, 2024
(a) The department
				shall ensure the privacy of patients and confidentiality of patient information
				transmitted or obtained pursuant to sections
				21a-254-2 to
				21a-254-6,
				inclusive, of the Regulations of Connecticut State Agencies, and shall ensure
				that the patient information collected, recorded, transmitted, and stored is
				maintained in accordance with applicable state and federal laws, rules and
				regulations.
(b) The department
				shall retain the prescription information collected pursuant to sections
				21a-254-2 to
				21a-254-6,
				inclusive, of the Regulations of Connecticut State Agencies,for a minimum of
				three years.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-3 - Disposition of drugs

Current through July 10, 2024
(a) Disposal of
			 undesired, excess, unauthorized, obsolete, or deteriorated controlled
			 substances shall be made by a registrant, person having title to, enforcement
			 or court official, executor of an estate, or any other person in the following
			 manner:
(1) By transfer to a person or firm
			 registered under the Federal Controlled Substances Act and authorized to
			 possess such controlled substances providing all state and federal required
			 procedures are complied with.
(2)
			 By following procedures as outlined in Sections 307.21 of the Code of Federal
			 Regulations.
(3) By the following
			 manner in the case of hospital pharmacies where small quantities of less than
			 No. 10 controlled substance units are involved on any separate occasion:
(a) By destruction in such a manner as to
			 render the controlled substance(s) nonrecoverable.
(b) By destruction conducted by a Connecticut
			 licensed pharmacist in the presence of another Connecticut licensed pharmacist
			 acting as a witness.
(c) By
			 maintaining a separate record of each such destruction indicating the date,
			 time, manner of destruction, the type, strength, form, and quantity of
			 controlled substance(s) destroyed, and the signatures of the pharmacist
			 destroying the controlled substance(s) and the pharmacist witness.
(4) By a manner rendering the
			 controlled substance(s) nonrecoverable in cases where such controlled
			 substance(s) are legally possessed by a person for his/her own personal use
			 pursuant to a bonafide medical condition.
(5) By surrender without compensation of such
			 controlled substance(s) to the Commissioner of Consumer Protection in all other
			 instances.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-4 - Manufacturers, wholesalers, distributors, importers, and exporters

Current through July 10, 2024
(a) Schedule II Stock if less than No. 250
			 controlled substance units shall be stored in an approved safe. If No. 250 or
			 more controlled substance units all schedule II controlled substances shall be
			 stored in an approved vault.
(b)
			 Schedule III, IV, V Stock shall be stored in an approved vault, approved safe
			 equipped with a separate effective electrical alarm system, or separate secure
			 locked caged area, room, or enclosure equipped with a separate effective
			 electrical alarm system. If a caged area or enclosure is used, such caged area
			 or enclosure must be completely enclosed. If a caged area is used, construction
			 must be of heavy gauge wire mesh having openings smaller than the smallest
			 controlled substance(s) containers stocked.
(c) All controlled substances in the process
			 of manufacture, distribution, transfer, or analysis shall be stored in such a
			 manner as to prevent diversion; shall be accessible only to the minimum number
			 of specifically authorized personnel essential for efficient operation; and
			 shall be returned to the required security location immediately after
			 completion of the procedure or at the end of the scheduled business day. If a
			 manufacturing process cannot be completed at the end of a working day, the
			 processing area or tanks, vessels, bins, or bulk containers containing
			 controlled substances must be securely locked inside an area or building which
			 affords adequate security.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-5 - Licensed pharmacies

Current through July 10, 2024
(a) Schedule II
			 Stock, if less than No. 150 controlled substance units a substantially
			 constructed completely enclosed locked wood or metal cabinet shall be used for
			 storage of all schedule II controlled substance stock. If No. 150 or more
			 controlled substance units an approved safe shall be used for storage of all
			 schedule II controlled substance stock. Pharmacies newly licensed and/or
			 relocating after Jan. 1, 1975 shall be required to store all schedule II
			 controlled substances in an approved safe.
(b) Schedule III, IV, V Stock shall be stored
			 in an approved safe, substantially constructed locked metal or wood cabinet, or
			 dispersed throughout stock within the pharmacy prescription compounding area
			 providing requirements of Section
			 21a-262-2(b)
			 are complied with and a loss, theft, or diversion of any controlled substance
			 in any schedule has not occurred.
(c) In every case where loss, theft,
			 burglary, or diversion of any controlled substance in any schedule has occurred
			 from a licensed pharmacy, the Commissioner of Consumer Protection shall
			 determine the appropriate storage and security requirements for all controlled
			 substances in such pharmacy, and shall require additional safeguards to ensure
			 the security of the controlled substances.
(d) The Commissioner of Consumer Protection
			 may require any licensed pharmacy(ies) to store any controlled substance stock
			 in an approved safe, or locked substantially constructed cabinet for security
			 purposes when overall conditions warrant additional safeguards.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-6 - Practitioners including but not limited to medical doctors, dentists, veterinarians, osteopaths, and podiatrists

Current through July 10, 2024
(a) Schedule II
			 and III Controlled Substance Stock, if total is No. 15 controlled substance
			 units or less shall be stored in a locked substantially constructed steel or
			 wood cabinet in a securely safeguarded location. If the total quantity of
			 schedule II and III controlled substance stock is more than 15 controlled
			 substance units, such stock shall be stored in an approved safe. In the case of
			 veterinary practitioners an additional No. 25 controlled substance units of
			 schedule II or III controlled substance stock of the barbiturate-type, for use
			 solely for animal anesthesia or animal euthenasia, may be stored in a locked
			 substantially constructed steel or wood cabinet.
(b) Schedule IV and V Controlled Substance
			 Stock shall be stored in a locked substantially constructed steel or wood
			 cabinet or in a securely safeguarded location.
(c) In no case shall a practitioner's
			 controlled substance stock be left unsecured or unattended in an examining
			 room, treatment room, automobile, or in any other location assessible to
			 nonauthorized persons.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-7 - Laboratories other than hospital clinical laboratories

Current through July 10, 2024
(a) Schedule I and II Controlled Substance
			 Stock shall be stored in an approved safe except where schedule II stock of the
			 barbiturate type is used solely for its sedative or anesthetic effect on
			 animals and not more than No. 10 Controlled Substance units are stocked, in
			 which cases security as outlined for schedule III controlled substances in
			 Section
			 21a-262-7(b)
			 will apply. In instances in laboratories where schedule I or II stock may be
			 unstable, of extremely small quantity, or of such a nature as to require
			 special storage conditions, the Commissioner of Consumer Protection may approve
			 of other security safeguards on an individual basis in lieu of those required
			 by section
			 21a-262-1 through
			 21a-262-10
			 inclusive.
(b) Schedule III, IV or
			 V Controlled Substances Stock shall be stored separately from other drugs and
			 substances in an approved safe or separate secure locked location accessible
			 only to the minimum number of specifically authorized personnel essential for
			 efficient operation.
(c) Controlled
			 Substances in the process of testing, use, or research shall be immediately
			 returned to the required storage location upon completion of each such
			 process.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-8 - Pharmacies or other areas wherein controlled substances are stored, prepared, or dispensed exclusive of those speciically referred to in section 21a-262-9 and section 21a-262-10 located within licensed hospitals, mental health hospitals, mental retardation facilities, training schools, correctional institutions, juvenile training or youth services facilities, educational institutions, health maintenance organizations, health facilities, and within other care giving institutions or establishments including those which are private, state, or municipally operated, and including hospital drug rooms, hospital satellite pharmacies, and hospital clinical laboratories

Current through July 10, 2024
(a) Schedule II and III Controlled Substance
			 Stock in quantities of less than No. 150 controlled substance units shall be
			 stored separately from other drugs and substances in a separate secure
			 substantially constructed locked metal or wood cabinet. In the case of Hospital
			 Clinical Laboratories, Schedule II Controlled Substance stock shall be stored
			 in an approved safe.
Schedule II and III controlled substance stock in quantities of
				No. 150 controlled substance units or more but less than No. 1000 controlled
				substance units shall be stored in an approved safe.
Schedule II and III controlled substance stock in quantities of
				No. 1000 controlled substance units or more shall be stored in a completely
				enclosed masonry room or equivalent equipped with a vault-type steel door with
				horizontal or vertical locking bolts, having a three-tumbler combination lock
				and a relocking device. The completely enclosed masonry room or equivalent, if
				operations require it to be opened for frequent access, must be equipped with a
				"day gate" which is self-closing and self-locking or the vault type steel door
				must be equipped with a key locking device or an equivalent day locking
				device.
Completely enclosed masonry rooms or equivalents constructed
				after January 1, 1975, must be equipped with an electrical alarm system which,
				when unauthorized entry is attempted, transmits a signal directly to a central
				station protection company, or a local or state police agency which has a legal
				responsibility to respond, or a 24-hour control station operated by the
				registrant.
(b) Schedule IV
			 and V Controlled Substance Stock shall be stored in a secure location within
			 the pharmacy prescription compounding area or drug room.
Schedule IV and V Controlled Substance Stock stored within
				hospital clinical laboratories shall be kept in a separate secure locked
				location.
(c) Controlled
			 Substance Stock within any such pharmacy shall not be accessible to other than
			 specifically authorized pharmacy personnel, and shall be handled by authorized
			 pharmacy personnel only.
Connecticut Administrative Code › Title 21a - Consumer Protection › 262 - Minimum Security and Safeguard Requirements for Storage and Handling of Controlled Substances › Section 21a-262-10 - Industrial health facilities, educational institution infirmaries, clinics, summer camps, and other institutions or establishments providing health care services including those which are group, private, state, and/or municipally operated

Current through July 10, 2024
(a) Schedule II and
			 III Controlled Substance Stock, if No. 15 controlled substance units or less
			 shall be stored separate from other drugs and substances in a separate secure
			 substantially constructed locked metal or wood cabinet.
Schedule II and III Controlled Substance Stock if in excess of
				No. 15 controlled substance units shall be stored in an approved safe.
(b) Schedule IV and V Controlled
			 Substance Stock shall be stored in a separate secure locked location or with
			 Schedule II and III Controlled Substances in compliance with security measures
			 as required per section
			 21a-262-10(a).
(c) Controlled Substances for Stock use shall
			 be purchased or obtained by the medical director or physician in charge from a
			 wholesaler or manufacturer of drugs, and shall be handled only by an authorized
			 physician, Connecticut licensed pharmacist, or Connecticut licensed nurse.
			 Controlled substances shall be the property of the medical director or
			 physician in charge who shall be responsible for security requirements and
			 record keeping procedures.
(d) The
			 same security requirements shall apply for controlled substances obtained
			 pursuant to patient(s) prescriptions as for stock controlled substances.
			 Controlled substances obtained pursuant to such individual patient(s)
			 prescriptions shall not be used for any other patient(s) and when no longer
			 required for the intended specific individual patient shall be securely kept
			 and safeguarded until properly disposed of.
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-1 - Drug enforcement program definitions (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-2 - Drug enforcement program description (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-5 - Safe neighborhoods program description (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-6 - Safe neighborhoods program funding and eligibility (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-7 - Guidelines for safe neighborhoods program components (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-8 - Application due date and process (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-9 - Safe neighborhoods program review criteria and process (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-10 - Supplanting of local funds prohibited (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 274a - Drug Enforcement and Safe Neighborhood Programs › Section 21a-274a-12 - Involuntary termination of grants (Repealed)

Current through July 10, 2024
For 2014 repeal, see
				  Sec.
				  54 of
				  Public
				  Act 14-187. (June 11,
				  2014)
Connecticut Administrative Code › Title 21a - Consumer Protection › 326 - Registration of Practitioners for Controlled Substances › Section 21a-326-1 - Definitions

Current through July 10, 2024
(a) "Abuse or Excessive Use of Drugs" means
			 the personal use of controlled substances by a practitioner or other registrant
			 in such dosage and frequency not warranted by an existing medical condition or
			 use of controlled substances solely for a stimulant, depressant, or
			 hallucinogenic effect which use is not within the medical consensus or stated
			 in the medical literature as acceptable or proper.
(b) "Controlled Substance Schedules" means
			 the grouping of drugs, schedules 1 through 5, as delineated in Section
			 21a-242 of Chapter
			 420b, Connecticut General Statutes or in regulations promulgated under the Code
			 of Federal Regulation. Any particular controlled substance shall be deemed to
			 be in the schedule wherein such controlled substance appears by its chemical or
			 generic name within Sec.
			 21a-242 of Chapter
			 420b, Connecticut General Statutes or in regulations promulgated under the Code
			 of Federal Regulation.
(c) "Course
			 of Professional Practice" means the limitation of prescribing, dispensing, or
			 administering of controlled substances for professional treatment authorized
			 pursuant to regulations and/or statutes of the appropriate state licensing
			 authority under which situations there must be a bona fide practitioner-patient
			 relationship. The prescribing or dispensing of controlled substances for
			 patients, friends, relatives, associates, and/or employees wherein a bona fide
			 practitioner-patient relationship does not exist or wherein the practitioner
			 has not medically evaluated the need for controlled substances shall not be
			 considered to be in the "course of professional practice."
(d) "Effective Controls Against Diversion"
			 means the implementation of the following controls on a regular basis necessary
			 for the prevention of diversion of controlled substances:
(1) Prescribing, dispensing, or administering
			 of controlled substances only after a proper medical evaluation.
(2) Maintaining of controlled substance
			 record keeping and security requirements pursuant to Chapter 420b of the
			 Connecticut General Statutes.
(3)
			 Providing for adequate security of prescription blanks to prevent thefts and/or
			 illegal use.
(4) Regular monitoring
			 of patient(s) conditions in instances wherein continued or prolonged treatment
			 with controlled substances is indicated.
(5) Refraining from knowingly prescribing
			 controlled substances for persons abusing such controlled substances and/or
			 using such controlled substances for purposes of maintenance of drug dependency
			 unless pursuant to state and federal regulations pertaining to treatment of
			 drug dependent persons.
(6)
			 Compliance with all state and federal statutes and regulations concerning
			 controlled substances.
Connecticut Administrative Code › Title 21a - Consumer Protection › 326 - Registration of Practitioners for Controlled Substances › Section 21a-326-2 - Registration applications and renewals

Current through July 10, 2024
Registration applications and renewals shall be on such forms
				as furnished by the Commissioner of Consumer Protection and shall whenever so
				indicated be signed by the applicant.
(a) All registration applications shall
			 contain all information required by the Commissioner of Consumer Protection.
			 Applications not inclusive of required data or those which are illegibly
			 executed may be returned for correction.
(b) It shall be the responsibility of all
			 practitioners, hospitals, or other institutions who propose to engage in
			 distributing, prescribing, administering, dispensing, or using any controlled
			 substance within this state to submit an application for registration with the
			 appropriate fee to the Commissioner of Consumer Protection. The Commissioner
			 shall issue a certificate of registration in accordance with the provisions of
			 Chapter 420c of the General Statutes.
(c) It shall be the responsibility of the
			 applicant to submit his/her registration renewal application to the
			 Commissioner at least one month prior to the expiration of his/her current
			 registration.
(d) All
			 practitioners, hospitals, clinics, or other authorized persons or facilities
			 wishing to prescribe, administer, or dispense controlled substances shall
			 obtain a certificate of registration issued by the commissioner of consumer
			 protection as mated by Section
			 21a-317
			 of the General Statutes. No controlled substance shall be prescribed,
			 administered, or dispensed until such registration has been approved by the
			 commissioner. Regulation fees shall not be prorated.
(e) For registration purposes applicants
			 shall be classified as follows:
(1)
			 Practitioner;
(2)
			 Hospital;
(3) Clinic;
(4) Others.
All practitioners shall designate their specific professional
				practice; e.g., M.D., dentist, veterinarian, osteopath or podiatrist on their
				application for registration. Other applicants shall designate their
				appropriate title; i.e., Ph.D., Director, Director of Pharmacy, Administrator,
				President, Manager, etc.
Connecticut Administrative Code › Title 21a - Consumer Protection › 326 - Registration of Practitioners for Controlled Substances › Section 21a-326-3 - Notification of failure to obtain or renew registration

Current through July 10, 2024
The Commissioner of Consumer Protection shall notify the
				Federal Drug Enforcement Administration or its successor, of the failure of any
				practitioner or researcher to obtain or renew a valid state registration; or of
				any administrative action taken by the Commissioner resulting in the denial,
				surrender, suspension, or revocation of a registration or the limitation of the
				controlled substance schedules of a registration.
Connecticut Administrative Code › Title 21a - Consumer Protection › 326 - Registration of Practitioners for Controlled Substances › Section 21a-326-4 - Responsibility of registrant

Current through July 10, 2024
(a) It shall be the
			 responsibility of a registrant who ceases to practice or who goes out of
			 business to notify the Commissioner in writing five (5) days before such
			 occurrence.
(b) It shall be the
			 responsibility of the registrant to notify the Commissioner within thirty (30)
			 days of any changes in information or data required on the registration
			 application pursuant to which any registration is issued.
Connecticut Administrative Code › Title 21a - Consumer Protection › 326 - Registration of Practitioners for Controlled Substances › Section 21a-326-5 - Registration of controlled substances

Current through July 10, 2024
(a) It shall be the
			 responsibility of the registrant to be registered in accordance with state and
			 federal controlled substance laws for those particular controlled substance
			 schedules incorporating those drugs used or to be used within the scope of
			 his/her professional practice.
(b)
			 A registrant may voluntarily surrender his/her controlled substance
			 registration privileges in any or all controlled substance schedules to the
			 Commissioner of Consumer Protection or may voluntarily refrain from registering
			 in those controlled substance schedules not applicable to his/her professional
			 practice or scientific research.
(c) The Commissioner of Consumer Protection
			 may in accordance with Sections
			 21a-323
			 and
			 21a-324
			 of the General Statutes limit the schedules for which the practitioner is
			 registered.
Connecticut Administrative Code › Title 21a - Consumer Protection › 336 - Banned Hazardous Substances › Section 21a-336-1 - Banned hazardous substances

Current through July 10, 2024
Under authority of General Statutes, Section 21-336(c), the
				Commissioner of Consumer Protection declares as a banned hazardous substance
				the following articles because the degree or nature of the hazard involved in
				the presence or use of such articles is such that labeling adequate to protect
				the public health and safety cannot be devised. As a banned hazardous
				substance, such articles shall be removed from commerce as of the effective
				date of each Subsection:
(a) products
			 containing butyl nitrite intended, or packaged in a form suitable, for use in a
			 household as an odorant, deodorant, air freshener, odorizer or for any other
			 purpose whereby such products are intended, or their primary functional purpose
			 is, to be breathed, inhaled or sniffed;
(b) any paint or other similar
			 surface-coating materials for consumer use that contain lead or lead compounds
			 and in which the lead content (calculated as lead metal) is in excess of 0.06
			 percent of the weight of the total nonvolatile content of the paint or the
			 weight of the dried paint film;
(c)
			 Obsolete.
(d) any stuffed toy
			 consisting of cotton, wool, hair, feathers, down, rubber, foam, man-made or
			 manufactured fibers, or miscellaneous fibers which contains any detectable
			 level of kerosene, as determined by the application of the best technology
			 available;
(e) any stuffed toy
			 consisting of cotton, wool, hair, feathers, down, rubber, foam, man-made or
			 manufactured fibers, or miscellaneous fibers which contains any detectable
			 level of polychlorinated biphenals (pcb's), as determined by the application of
			 the best technology available.
Connecticut Administrative Code › Title 21a - Consumer Protection › 340f - Residential Stair Lift Technician's License › Section 21a-340f-1 - Definitions

Current through July 10, 2024
(1) "Apprentice trainee" means any person
			 registered with the Department of Consumer Protection for the purpose of
			 learning a skilled trade.
(2)
			 "Private residence" means a residential dwelling containing a residential stair
			 lift that is not intended for general public use.
(3) "Residential stair lift" means an
			 inclined residential stairway chair lift with a fixed in place swivel single
			 seat and its internal components, installed in or at a private
			 residence.
(4) "Residential stair
			 lift work" means the installation, repair, replacement, maintenance or
			 alteration of residential stair lifts installed in or at a private residence
			 for use on a stairway structure capable of safely supporting the loads imposed
			 on such structure. Residential stair lift work does not include non-structural
			 or cosmetic work on a residential stair lift.
Connecticut Administrative Code › Title 21a - Consumer Protection › 340f - Residential Stair Lift Technician's License › Section 21a-340f-2 - Qualifications to obtain licensure

Current through July 10, 2024
A residential stair lift technician license may be issued by
				the Department of Consumer Protection to any applicant registered as an
				apprentice trainee with the department who (1) has experience performing
				residential stair lift work of not less than ten new installations, (2) has
				completed a training program of instruction, which shall include, but need not
				limited to, a review of applicable state and federal laws, codes, standards and
				work site safety requirements of not less than twenty hours related to
				residential stair lift work, which program has been reviewed and approved by
				the Commissioner of Consumer Protection, and (3) has paid the license fee
				specified in section
				20-340f
				of the Connecticut General Statutes to the department.
Connecticut Administrative Code › Title 21a - Consumer Protection › 340f - Residential Stair Lift Technician's License › Section 21a-340f-3 - License Transferability

Current through July 10, 2024
Licenses issued to residential stair lift technicians shall not
				be transferable or assignable and the failure to receive a notice of expiration
				or a renewal application for a license shall not exempt a residential stair
				lift technician from the obligation to renew said license.
Connecticut Administrative Code › Title 21a - Consumer Protection › 342 - Repurchase of Banned Hazardous Substances › Section 21a-342-1 - Repurchase of banned hazardous substances

Current through July 10, 2024
(a)
Scope.
This section establishes the procedures under which a
			 banned hazardous article or substance which is required to be repurchased under
			 Section
			 21a-346
			 of the Act shall be repurchased.
(b)
Definitions.
For the
			 purposes of this section:
(1) The term
			 "manufacturer" includes any person who manufactures or imports an article or
			 substance for distribution or sale in the State of Connecticut, except that in
			 the case of an article or substance distributed or sold under a name other than
			 that of the actual manufacturer of the article or substance, the term
			 "manufacturer" includes any person under whose name the article or substance is
			 distributed or sold.
(2) The term
			 "distributor" includes any person who sells an article or substance at
			 wholesale.
(3) The term "dealer"
			 includes any person who sells an article or substance at retail. A dealer who
			 sells at wholesale an article or substance subject to this section shall, with
			 respect to that sale, be considered the distributor of that article or
			 substance.
(4) The term "person"
			 includes an individual, partnership, corporation or association, or his or its
			 legal representative or agent.
(5)
			 The term "purchase price" means the amount of money paid to acquire an article
			 or substance, including all taxes, but excluding transportation or shipping
			 costs and finance, interest, or service charges.
(6) The term "reasonable and necessary
			 transportation charges," when used in connection with the return of an article
			 or substance to a dealer, means:
(i) The
			 actual costs incurred in returning the product in any manner reasonably
			 specified by the dealer, including personal conveyance; or
(ii) The actual costs incurred in returning
			 the product by mail, commercial carrier, or any other manner, including
			 personal conveyance, reasonably utilized in the absence of specific
			 instructions by the dealer.
(7) The term "reasonable and necessary
			 expense" when used in connection with the return of an article or substance to
			 a distributor or manufacturer shall include the cost of labor, administration,
			 and transportation in the handling, processing, and shipping of that
			 product.
Connecticut Administrative Code › Title 21a - Consumer Protection › 342 - Repurchase of Banned Hazardous Substances › Section 21a-342-2 - Warning label concerning small parts

Current through July 10, 2024
(a)
Scope.
This section establishes the standards for the warning
			 label that is required by Section
			 21a-337(10)
			 of the State Child Protection Act. Toys or other articles which are exempted by
			 16
			 CFR 1501.3 and paper, fabric, yarn, fuzz,
			 elastic and string are exempted from the provisions of this section.
(b)
Content.
The warning label
			 shall contain:
(1) the signal word "Warning";
			 and
(2) a statement of hazard that
			 warns that the contents include small parts which pose a hazard for children
			 under the age of three.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-2 - Requirements for issuing written certifications to the department

Current through July 10, 2024
(a) The department shall only accept written
			 certifications for the palliative use of marijuana when the physician or APRN:
(1) Holds an active license under chapter 370
			 or 378 of the Connecticut General Statutes and is in good standing;
(2) Holds an active department controlled
			 substance practitioner registration, is in good standing and is eligible to
			 prescribe schedule II controlled substances;
(3) Holds an active federal Drug Enforcement
			 Administration controlled substance registration, is in good standing and is
			 eligible to prescribe schedule II controlled substances;
(4) Is registered with and reviews a
			 patient's prescription history in the Prescription Monitoring Program;
			 and
(5) Is not engaged in any
			 conduct prohibited by the Act or sections
			 21a-408-1 to 21a-408-72,
			 inclusive, of the Regulations of Connecticut State Agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-3 - Requirements for maintaining patient medical records

Current through July 10, 2024
(a) A physician or APRN shall maintain
			 medical records, as described in section
			 19a-14-40 of the Regulations of
			 Connecticut State Agencies, for all patients for whom the physician or APRN has
			 issued a written certification.
(b)
			 A physician or APRN shall make a copy of such medical records reasonably
			 available to the commissioner, to other state agencies and to state and local
			 law enforcement agencies for the purpose of enabling the department or other
			 agency to ensure compliance with the Act and sections
			 21a-408-1 to 21a-408-72,
			 inclusive, of the Regulations of Connecticut State Agencies or for the purpose
			 of investigating or prosecuting a violation of any provision of the Connecticut
			 General Statutes or the Regulations of Connecticut State Agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-4 - Prohibited acts of physicians or APRNs

Current through July 10, 2024
(a) A physician
			 or APRN who has issued or intends to issue a written certification shall not:
(1) Directly or indirectly accept, solicit,
			 or receive anything of value from a dispensary, dispensary facility backer,
			 dispensary facility employee, producer, producer backer, production facility
			 employee, provider of paraphernalia or any other person associated with a
			 dispensary facility or production facility, except as permitted by section
			 21a-70e of the Connecticut General Statutes;
(2) Offer a discount or any other thing of
			 value to a qualifying patient based on the patient's agreement or decision to
			 use a particular primary caregiver, dispensary, dispensary facility or
			 marijuana product;
(3) Examine a
			 qualifying patient for purposes of diagnosing a debilitating medical condition
			 at a location where marijuana or paraphernalia is acquired, distributed,
			 dispensed, manufactured, sold, or produced; or
(4) Directly or indirectly benefit from a
			 patient obtaining a written certification. Such prohibition shall not prohibit
			 a physician or APRN from charging an appropriate fee for the patient
			 visit.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-5 - Enforcement actions against physicians or APRNs

Current through July 10, 2024
(a)
			 The commissioner may, after a hearing conducted pursuant to the Uniform
			 Administrative Procedure Act, sections 4-166 to 4-189, inclusive, of the
			 Connecticut General Statutes, issue an order to place conditions upon, revoke
			 or suspend a physician's or APRN's controlled substance practitioner
			 registration or to restrict a physician's or APRN's controlled substance
			 practitioner registration so as to prohibit the physician or APRN from issuing
			 written certifications if the physician or APRN has:
(1) Failed to comply with any provision of
			 the Act or sections
			 21a-408-1 to 21a-408-72,
			 inclusive, of the Regulations of Connecticut State Agencies;
(2) Failed to comply with any provision of
			 state statute or regulation concerning legend drugs or controlled substances;
			 or
(3) Intentionally or negligently
			 permitted another person to issue written certifications under the physician's
			 or APRN'sname.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-6 - Patient and primary caregiver registration

Current through July 10, 2024
(a) A
			 qualifying patient for whom a physician or APRN has issued a written
			 certification, and the qualifying patient's primary caregiver where applicable,
			 shall register with the department on forms, and in a manner, prescribed by the
			 commissioner.
(b) The form
			 prescribed by the commissioner may require the qualifying patient or primary
			 caregiver to grant permission for the department to:
(1) Determine whether the patient is an
			 inmate confined in a correctional institution or facility under the supervision
			 of the Department of Correction; and
(2) Conduct a background check of the primary
			 caregiver for the purpose of determining if such applicant has been convicted
			 of a violation of any law pertaining to the illegal manufacture, sale or
			 distribution of a controlled substance.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-7 - Denial of a qualifying patient or primary caregiver registration application

Current through July 10, 2024
(a) The department
			 may deny an application or renewal of a qualifying patient's registration
			 certificate if the applicant:
(1) Does not
			 meet the requirements set forth in the Act or section
			 21a-408-6 of the Regulations of
			 Connecticut State Agencies;
(2)
			 Fails to properly complete the application;
(3) Does not provide acceptable proof of
			 identity, residency or age to the department;
(4) Provides false, misleading or incorrect
			 information to the department;
(5)
			 Has had a qualifying patient's registration denied, suspended or revoked by the
			 department in the previous six months;
(6) Has not paid all applicable fees as
			 required by section
			 21a-408-29 of the Regulations of
			 Connecticut State Agencies;
(7) Has
			 a written certification issued by a physician or APRN who is not authorized to
			 certify patients for marijuana; or
(8) Is a minor or needs a primary caregiver
			 according to the written certification issued by the physician and:
(A) The applicant has not designated a
			 primary caregiver; or
(B) The
			 department has denied the application of the primary caregiver designated by
			 the qualifying patient.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-10 - Precautions for preventing the loss, theft or misuse of marijuana by patients and caregivers

Current through July 10, 2024
(a) Qualifying
			 patients and primary caregivers marijuana in a secure location to prevent
			 theft, loss or access by unauthorized persons.
(b) Qualifying patients and primary
			 caregivers shall carry their registration certificate with them whenever they
			 are in possession of marijuana.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-11 - Proper disposal of marijuana by patients or caregivers

Current through July 10, 2024
A patient or caregiver shall dispose of all usable marijuana in
				the patient's or caregiver's possession no later than ten calendar days after
				the expiration of the patient's registration certificate, if such certificate
				is not renewed, or sooner should the patient no longer wish to possess
				marijuana for palliative use. A patient or caregiver shall complete such
				disposal by one of the following methods:
(1) By rendering the marijuana
			 non-recoverable in accordance with the department's proper disposal
			 instructions, which are available on the department's Internet web site at
www.ct.gov/dcp
;
(2) By depositing it in a Connecticut police
			 department medication drop-box; or
(3) By disposing of the marijuana at a
			 government-recognized drug take-back program located in Connecticut.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-12a - Additional Debilitating Medical Conditions

Current through July 10, 2024
In accordance with the procedures set forth in section
				21a-408a-12 of the Regulations of Connecticut State Agencies, the following
				medical conditions, medical treatments or diseases shall be added to the list
				of debilitating medical conditions:
(a) For patients eighteen years of age or
			 older:
(1) Sickle cell disease;
(2) Post laminectomy syndrome with chronic
			 radiculopathy;
(3) Severe psoriasis
			 and psoriatic arthritis;
(4)
			 Amyotrophic lateral sclerosis;
(5)
			 Ulcerative colitis;
(6) Complex
			 regional pain syndrome, Type 1 and Type II;
(7) Spasticity or Neuropathic Pain Associated
			 with Fibromyalgia;
(8) Severe
			 Rheumatoid Arthritis;
(9) Post
			 Herpetic Neuralgia;
(10) Muscular
			 Dystrophy;
(11) Hydrocephalus with
			 Intractable Headache;
(12)
			 Intractable Headache Syndromes;
(13) Neuropathic Facial Pain;
(14) Osteogenesis Imperfecta;
(15) Chronic Neuropathic Pain Associated with
			 Degenerative Spinal Disorders;
(16)
			 Interstitial Cystitis;
(17)
			 Intractable Neuropathic Pain that is unresponsive to standard medical
			 treatments;
(18) Median Arcuate
			 Ligament Syndrome;
(19) Tourette
			 Syndrome;
(20) Vulvodynia and
			 vulvar burning;
(21) Chronic Pain
			 of at least 6 months duration associated with a specified underlying chronic
			 condition refractory to other treatment intervention;
(22) Ehlers-Danlos Syndrome associated with
			 Chronic Pain; and
(23) Chronic
			 Pancreatitis.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-13 - Number of dispensaries and dispensary facilities

Current through July 10, 2024
(a)
			 Only a dispensary at a dispensary department may dispense marijuana.
(b) The commissioner shall issue at least one
			 dispensary facility license and may issue additional dispensary facility
			 licenses upon a determination that additional dispensary facilities are
			 desirable to assure access to marijuana for qualifying patients. Such
			 determination shall be made based on the size and location of the dispensary
			 facilities in operation, the number of qualifying patients registered with the
			 department and the convenience and economic benefits to qualifying
			 patients.
(c) Each dispensary
			 facility may employ no more than fifteen dispensaries at a time without prior
			 approval from the commissioner, one of whom shall be designated as the
			 dispensary facility manager.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-14 - Dispensary facility license selection

Current through July 10, 2024
(a) The
			 department shall publish on its Internet web site, and in such other places as
			 the department deems appropriate, a notice of open applications for dispensary
			 facility licenses. Such notice shall include, but not be limited to:
(1) The maximum number of licenses to be
			 awarded;
(2) Information on how to
			 obtain an application;
(3) The
			 deadline for receipt of applications;
(4) Acceptable methods for submitting an
			 application;
(5) The preferred
			 locations, if any, for the dispensary facility licenses; and
(6) The criteria that shall be considered in
			 awarding the dispensary facility licenses.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-16 - Dispensary facility employee licenses and registrations

Current through July 10, 2024
(a) No person shall act as a dispensary
			 without a license issued by the department under the Act and section
			 21a-408-25 of the Regulations of
			 Connecticut State Agencies.
(b) No
			 person shall act as a dispensary technician without being registered with the
			 department under the Act and section
			 21a-408-25 of the Regulations of
			 Connecticut State Agencies.
(c) No
			 person shall be employed or retained as any other type of dispensary facility
			 employee without being at least 18 years of age and being registered by the
			 department under the Act and section
			 21a-408-25 of the Regulations of
			 Connecticut State Agencies.
(d) Any
			 dispensary facility backer, or other person who will exercise control over, or
			 have management responsibility for, a dispensary facility shall be registered
			 with the department pursuant to section
			 21a-408-25 of the Regulations of
			 Connecticut State Agencies.
(e)
			 Only a pharmacist who is in good standing and has an active pharmacist license
			 issued by the department may apply for and receive a dispensary
			 license.
(f)
(1) Only a person who has held an active
			 pharmacy technician registration in Connecticut within the five years prior to
			 the application, who is 18 years of age or older, and is currently in good
			 standing, or was in good standing at the time his or her registration lapsed,
			 may apply for and receive a dispensary technician registration.
(2) Notwithstanding the provisions of
			 subdivision (1) of this subsection, a person may apply for a dispensary
			 technician registration renewal or reinstatement if such person has held an
			 active pharmacy technician registration or dispensary technician registration
			 in Connecticut within the five years prior to the application and is currently
			 in good standing, or was in good standing at the time his or her registration
			 lapsed.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-18 - Notification of changes by dispensary and dispensary technician

Current through July 10, 2024
Every dispensary and dispensary technician whose place of
				employment, name or home address changes shall notify the department of such
				change on a form prescribed by the commissioner, no more than five business
				days after the change becomes effective.
Connecticut Administrative Code › Title 21a - Consumer Protection › 408 - Palliative Use of Marijuana › Section 21a-408-19 - Number of producers

Current through July 10, 2024
(a) The department
			 shall issue at least three, but no more than ten, producer licenses.
(b) Prior to issuing any additional producer
			 licenses, the commissioner shall determine that additional producers are
			 desirable to assure access to marijuana for qualifying patients, which
			 determination shall be made based on the size and location of the production
			 facilities in operation, the amount of marijuana each production facility is
			 producing, the number of qualifying patients registered with the department and
			 the convenience and economic benefits to qualifying patients or dispensary
			 facilities.